Previous
Previous Product Image

Semaglutide (5mg)

Original price was: $95.25.Current price is: $89.00.
Next

Cagrilintide (5mg)

$97.50
Next Product Image

Retatrutide 10mg (12mg)

Original price was: $129.00.Current price is: $99.00.

Specification Details
Product Name Retatrutide
Quantity 12 mg per vial
Container Glass Vial
Presentation Lyophilized Powder
Molecular Formula C223H343F3N46O70
Molecular Weight 4845.44 g/mol
PubChem CID 474492335
CAS Number 2381089-83-2
Synonyms LY-3437943, NOP2Y096GV
Research Applications Weight Loss and Obesity, Type 2 Diabetes, Fatty Liver Disease

Description

This product is prepared for LABORATORY RESEARCH USE ONLY and may not be used for other purposes.


Buy Retatrutide 10mg (12mg) | Retatrutide Peptide Research

What is Retatrutide?

Retatrutide is a novel investigational peptide being studied as a potential multi-receptor agonist for its significant metabolic and weight-loss effects. It is designed to target the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors, creating a synergistic effect that may help regulate glucose metabolism, appetite, and energy expenditure.

Retatrutide has gained attention in clinical research for its potential to manage obesity, type 2 diabetes, and other metabolic disorders. Its unique triple-receptor mechanism differentiates it from existing single-receptor GLP-1 agonists.

Research Applications

Retatrutide is being investigated for its potential roles in:

  • Significant weight loss through appetite suppression and enhanced energy expenditure
  • Improved glycemic control in metabolic disorders such as type 2 diabetes
  • Modulation of lipid metabolism to reduce cardiovascular risk factors
  • Exploration as a therapeutic agent for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)
  • Synergistic effects in improving overall metabolic health

Retatrutide Structure and Mechanism

Property Description
Molecular Formula C187H291N45O59
Molecular Weight ~4.3 kDa
Mechanism of Action Multi-receptor agonist targeting GLP-1, GIP, and glucagon receptors to regulate glucose, appetite, and energy balance

In clinical studies, Retatrutide has demonstrated the ability to significantly reduce body weight and improve metabolic markers over a treatment period of several weeks.

Legal Disclaimer

This product is sold as a pure research compound and is not intended for human consumption or use as a dietary supplement, drug, or treatment. It is provided solely for laboratory research purposes and must not be used for diagnostic or therapeutic purposes, in food, cosmetics, or any medical applications.

The statements on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition. All products are for research and development use only.

Important Safety Information

  • Keep this product out of the reach of children.
  • Limited research is available on this material, and improper handling or use may pose risks or result in adverse effects.
  • This product is sold solely as a raw material for research purposes, and its purity and quality are attested exclusively for these purposes.
  • It is intended for handling only by qualified researchers with the necessary knowledge and equipment to safely manage such materials.

By purchasing, you agree to indemnify Molecular Solutions Peptides against any adverse effects that may arise from improper handling or use of this product.

Educational Notice

All information on this website is provided solely for educational purposes. These products are not pharmaceuticals or medications. The Food and Drug Administration (FDA) has not approved them for the treatment, prevention, or cure of any disease, medical condition, or ailment.

Shopping cart

0
image/svg+xml

No products in the cart.

Continue Shopping